[Research progress of long noncoding RNA in atopic dermatitis]

Area of Science:

• Molecular Biology
• Dermatology
• Immunology

Background:

• Atopic dermatitis (AD) is a prevalent chronic inflammatory skin disease with complex pathogenesis.
• Key factors in AD include genetic susceptibility, impaired skin barrier function, and immune system dysregulation.
• Long noncoding RNAs (lncRNAs), RNA molecules longer than 200 nucleotides that do not encode proteins, are recognized for their roles in various diseases.

Purpose of the Study:

• To review current research on the involvement of lncRNAs in the pathogenesis of atopic dermatitis.
• To summarize the abnormal expression patterns of lncRNAs observed in AD patients.
• To provide insights into the potential of lncRNAs as therapeutic targets for AD.

Main Methods:

• Literature review of studies investigating lncRNA expression and function in atopic dermatitis.
• Analysis of research findings on the role of specific lncRNAs in AD development.
• Synthesis of information regarding the connection between lncRNA dysregulation and AD pathology.

Main Results:

• Numerous lncRNAs have been found to be abnormally expressed in patients with atopic dermatitis.
• These dysregulated lncRNAs are involved in the intricate mechanisms driving AD development.
• Evidence suggests lncRNAs contribute to the inflammatory processes characteristic of AD.

Conclusions:

• Abnormal lncRNA expression is a significant factor in the pathogenesis of atopic dermatitis.
• lncRNAs represent promising biomarkers and potential therapeutic targets for managing AD.
• Further research into lncRNA function in AD could lead to novel treatment strategies.